Results 141 to 150 of about 93,886 (309)

Epidemiology of Huntington’s Disease in the United States Medicare and Medicaid Populations [PDF]

open access: hybrid, 2022
Alex Exuzides   +6 more
openalex   +1 more source

Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes

open access: yesEpilepsia Open, EarlyView.
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola   +3 more
wiley   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

Fused kernel-spline smoothing for repeatedly measured outcomes in a generalized partially linear model with functional single index

open access: yes, 2015
We propose a generalized partially linear functional single index risk score model for repeatedly measured outcomes where the index itself is a function of time.
Jiang, Fei, Ma, Yanyuan, Wang, Yuanjia
core   +1 more source

Additional file 7 of miR-34a-5p as molecular hub of pathomechanisms in Huntington’s disease

open access: gold, 2023
Martin Hart   +6 more
openalex   +1 more source

Therapeutic advances in neural regeneration for Huntington's disease

open access: yesNeural Regeneration Research
Huntington's disease is a neurodegenerative disease caused by the expansion mutation of a cytosine-adenine-guanine triplet in the exon 1 of the HTT gene which is responsible for the production of the huntingtin (Htt) protein. In physiological conditions,
Francesco D'Egidio   +5 more
doaj   +1 more source

Identifying Morphological and Functional Changes in a Caenorhabditis elegans Neuronal Aging Model of Huntington’s Disease [PDF]

open access: yes, 2012
• Evaluate the effects of aging on neuronal morphology and gentle touch response in a C. elegans model of Huntington's disease • Establish that our RNAi method in our two genetic strains, Huntington’s disease model ID1 and control ID245, is selective ...
Parker, Cyrena
core  

Nutritional Value and Memory‐Improving Effects of Seven Major Nuts: A Comprehensive Study Using Network Pharmacology and In Vivo Assays

open access: yesFood Frontiers, EarlyView.
This study highlights the memory‐enhancing effects of walnuts, almonds, and Torreya, with walnuts showing the strongest potential to improve cognitive function and delay brain aging. ABSTRACT This study explored the memory‐enhancing potential of seven commercially available nuts through nutritional profiling, metabolomics, network pharmacology, and ...
Jiamin Chen   +10 more
wiley   +1 more source

Imaging Studies of Aging, Neurodegenerative Disease, and Alcoholism. [PDF]

open access: yes, 1995
Neurodegenerative diseases such as Alzheimers disease, disorders such as alcoholism, and the aging process can lead to impaired cognitive function and dementia.
Eberling, Jamie, JAGUST, William J
core  

Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutation in the huntingtin gene on chromosome 4, leading to progressive cognitive decline, motor impairment, and functional disability. Although balance impairment is recognized in HD, its onset and evolution with disease stage remain poorly ...
Japleen Kaur   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy